Advancing regenerative medicine and maximising the gift of donation through science and innovation.
The LifeNet Health Institute of Regenerative Medicine (IRM), established in 2012, serves as a global centre of excellence for research and development【698215662195761†L148-L160】. Its focus is on new medical applications for allografts and tissue engineering to maximise the gift of donation【698215662195761†L148-L156】. The mission is to apply regenerative medicine principles to enhance bioimplants and develop novel therapeutic approaches derived from, or designed to enhance, tissue allografts and organ transplantation【698215662195761†L148-L156】.
As home to LifeNet Health’s R&D operations, the IRM is committed to improving healing across multiple fields【698215662195761†L158-L163】. Areas of focus include:
Explore next‑generation grafts and bioengineered constructs designed to restore function and maximise the donor gift.
Learn how LifeNet Health cultivates high‑quality cell lines for research, product development and therapeutic applications.
Bridge the gap from bench to bedside with studies that accelerate the clinical adoption of regenerative therapies.
Follow the rigorous design and testing processes that turn concepts into safe, effective medical products.
Advancing the science of valve repair, vascular grafts and cardiac tissue regeneration.
LifeNet Health collaborates with universities, hospitals and industry partners to push regenerative medicine forward. If you’re interested in partnering on research, please fill in the form below.